Literature DB >> 9629399

Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients.

I Lopes-Cendes1, H G Teive, M E Calcagnotto, J C Da Costa, F Cardoso, E Viana, J A Maciel, J Radvany, W O Arruda, P C Trevisol-Bittencourt, P Rosa Neto, I Silveira, C E Steiner, W Pinto Júnior, A S Santos, Y Correa Neto, L C Werneck, A Q Araújo, G Carakushansky, L R Mello, L B Jardim, G A Rouleau.   

Abstract

Spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2) and Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) are three distinctive forms of autosomal dominant spinocerebellar ataxia (SCA) caused by expansions of an unstable CAG repeat localized in the coding region of the causative genes. Another related disease, dentatorubropallidoluysian atrophy (DRPLA) is also caused by an unstable triplet repeat and can present as SCA in late onset patients. We investigated the frequency of the SCA1, SCA2, MJD/SCA3 and DRPLA mutations in 328 Brazilian patients with SCA, belonging to 90 unrelated families with various patterns of inheritance and originating in different geographic regions of Brazil. We found mutations in 35 families (39%), 32 of them with a clear autosomal dominant inheritance. The frequency of the SCA1 mutation was 3% of all patients; and 6% in the dominantly inherited SCAs. We identified the SCA2 mutation in 6% of all families and in 9% of the families with autosomal dominant inheritance. The MJD/SCA3 mutation was detected in 30% of all patients; and in the 44% of the dominantly inherited cases. We found no DRPLA mutation. In addition, we observed variability in the frequency of the different mutations according to geographic origin of the patients, which is probably related to the distinct colonization of different parts of Brazil. These results suggest that SCA may be occasionally caused by the SCA1 and SCA2 mutations in the Brazilian population, and that the MJD/SCA3 mutation is the most common cause of dominantly inherited SCA in Brazil.

Entities:  

Mesh:

Year:  1997        PMID: 9629399     DOI: 10.1590/s0004-282x1997000400001

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

Review 1.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

2.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

3.  Dentatorubro-Pallidoluysian Atrophy (DRPLA) among 700 Families with Ataxia in Brazil.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Gabriel Vasata Furtado; Tailise Conte Gheno; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

Review 4.  The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review.

Authors:  Hélio A G Teive; Alex T Meira; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Mov Disord Clin Pract       Date:  2019-08-16

5.  Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families.

Authors:  Hélio A G Teive; Renato P Munhoz; Walter O Arruda; Iscia Lopes-Cendes; Salmo Raskin; Lineu C Werneck; Tetsuo Ashizawa
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 6.  Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries.

Authors:  Ana F Castro; Joana R Loureiro; José Bessa; Isabel Silveira
Journal:  Genes (Basel)       Date:  2020-11-27       Impact factor: 4.096

Review 7.  Cognitive dysfunction in spinocerebellar ataxias.

Authors:  Helio Afonso Ghizoni Teive; Walter Oleschko Arruda
Journal:  Dement Neuropsychol       Date:  2009 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.